We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer-BioNTech COVID-19 Vaccine Moves Into Pivotal Trial
Pfizer-BioNTech COVID-19 Vaccine Moves Into Pivotal Trial
Pfizer’s and BioNTech’s experimental COVID-19 vaccine BNT162b2 has been chosen for a phase 2/3 efficacy study of 9,000 participants following its success in a phase 1 trial.